OncoSil Medical (ASX:OSL)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
Closing Bell: ASX bows out lower on last day of 2024, its best year since 2021
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
Rise and Shine: Everything you need to know before the ASX opens
Health Check: The Winner Takes It All as US investors back advanced biotech plays
MoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechs
Alive and Kicking: Respiri promises breath of life to bottom line after inking US distribution deal
Closing Bell: Origin, Cochlear dive on earnings; RBA rate cut looks less likely after jobs report
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
ASX July Winners: The best 50 stocks in a strong month for markets
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
Market Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US report
